ScholarMate
English简体中文繁體中文
Customer service: 400-1616-289
Sign inSign up
Journal article

The efficacy and safety of Sanqi Qushi Granule in patients with idiopathic membranous nephropathy --protocol of a multicenter, randomized control trial (SQ-AUTUMN)

Li, Chuang; Shan, Wenjun; Liang, Xing; Zhang, Qinghua; Qin, Xindong; Jiang, Sha; Hong, Xiaofan; Wang, Lijuan; Li, Ping; Gu, Haowen; Wang, Yi; Bao, Kun*广东省人民医院; 广州中医药大学
BMC Complementary Medicine and Therapies2023-4-27DOI: 10.1186/s12906-023-03950-9
7Reads
CiteSave
Share

Abstract

Background Adult nephropathy is mainly caused by idiopathic membranous nephropathy (IMN). In cases of proteinuria, Modified Ponticelli Regimens (MPR) are often successful. However, it can cause adverse side effects. Oral Sanqi Qushi Granule (SQG) with MPR is effective in patients with IMN. However, whether it can improve the remission rate of IMN and shorten the remission time is unknown. In this trial, SQG with MPR on IMN will be evaluated clinically for its efficacy and safety.Methods We will randomly assign IMN patients who meet the criteria to receives SQG plus cyclical Cyclophosphamide (CTX)/steroids or with placebo plus cyclical CTX/steroids for 6 months. A 12-month follow-up will be conducted on them. Status of remission will be used to assess treatment efficacy.Discussio nThis study aims to appraise whether treatment with SQG plus cyclical CTX/steroids is superior to placebo plus cyclical CTX/steroids in the remission rate of patients with adult IMN. Adverse events of SQG plus MPR will be also evaluated for further researches about Chinese Medicine and MPR on whether it can improve the remission rate of IMN in half a year and shorten the remission time and relieve adverse effects will also be clarified.

Disciplines and keywords

Keywords
Sanqi Qushi GranuleModified Ponticelli RegimenCyclophosphamideSteroidIdiopathic membranous nephropathyRandomized controlled trial
Related
Loading…
  • Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study
    Yang, Lihong; Chen, Xueyin; Li, Chuang; Xu, Peng; Mao, Wei; Liang, Xing; Zuo, Qi; Ma, Weizhong; Guo, Xinfeng*; Bao, Kun*Frontiers in Pharmacology, 2022, 12: 760482.Cited by 2
  • Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis
    Wang, Dan; Wang, Lijuan; Zhang, Mingrui; Li, Ping; Zhang, Qinghua; Bao, Kun*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(9).
  • 不同治疗方案对特发性膜性肾病疗效的临床对照研究
    罗曼宇; 刘丽华; 刘声茂; 张冬梅临床肾脏病杂志, 2019, (11): 798-802.
View all →

Publication info

Publication status
Published
Journal
BMC Complementary Medicine and Therapies
Publication date
2023-04-27
Volume / issue
Vol. 23, Issue 1
Pages
134
DOI
10.1186/s12906-023-03950-9
Output indexing
SCIE
Funding acknowledgment
Special Project of State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2021ZZ36, SZ2021ZZ09]; National Natural Science Foundation of China [81974565]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]; Natural Science Foundation of Guangdong Province [2022A1515011628]; Guangzhou Science and Technology Plan Project [202102010212]

Authors

  • L

    Li, Chuang (First author)

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • S

    Shan, Wenjun

    2 · guangzhou univ chinese med

View all 12 authorsShow fewer authors
  • L

    Liang, Xing

    guangdong prov hosp

  • Z

    Zhang, Qinghua

    guangdong prov hosp

  • Q

    Qin, Xindong

    guangdong prov hosp

  • J

    Jiang, Sha

    guangdong prov hosp

  • H

    Hong, Xiaofan

    guangdong prov hosp

  • W

    Wang, Lijuan

    2 · guangzhou univ chinese med

  • L

    Li, Ping

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • G

    Gu, Haowen

    2 · guangzhou univ chinese med

  • W

    Wang, Yi

    2 · guangzhou univ chinese med

  • B

    Bao, Kun (Corresponding)

    guangdong prov hosp · 2 · guangzhou univ chinese med

Sign in for more features

  • Save this paper in My collections
  • Claim your outputs and generate promotion materials
  • Follow authors for new outputs
  • Join groups and collaborate
Sign up / Sign in

Products

  • ScholarMate
  • InnoCity
  • IRISaaS

Support

  • Help Center
  • Privacy Policy
  • Terms of Service

Contact

Online support: []
Customer service: 400-1616-289
Email: support@scholarmate.com

Follow or download ScholarMate

WeChat QR code
WeChat official account
App download QR code
Download the app
OutputsResearchersResearch institutionsResearch newsIRISaaS

©2026 深圳市科研之友网络服务有限公司

Public security registration badge粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417